Study on the killing effect of DC-CTL targeting HBV-C, E and X genes on HBV in vitro and the immune mechanism
李雅琴,刘勇,江孝青,张慧,蔡月明,刘泽华,陈毅华,于岩岩,陈俊辉
DOI: https://doi.org/10.3760/cma.j.issn.1673-4394.2022.03.002
2022-01-01
International Journal of Immunology
Abstract:Objective:To investigate the function of T cells recognizing hepatitis B virus (HBV) specific antigens presented by autologous dendritic cell (DC), and explored the specific killing effect of cytotoxic T lymphocytes (CTLs) targeting HBV-C, E and X genes on target cells in vitro.Methods:Recombinant adeno-associated virus (rAAV) was obtained by loading HBV-C, HBV-E and HBV-X antigens into adeno-associated virus (AAV) by gene recombination technique. Peripheral blood mononuclear cells (PBMC) were isolated by Ficoll method and transfected into monocytes by HBV-C-rAAV, HBV-E-rAAV and HBV-X-rAAV respectively, finally differentiated into mature DC. The DC were divided into four groups: negative control group (non-transfection group) and HBV-C-rAAV/DC, HBV-E-rAAV/DC, HBV-X-rAAV/DC group (transfection groups). The transfection efficiency of rAAV, the expression of marker molecules on DCs, and the secretion of interleukin (IL) -10 and IL-12 from DC were detected with flow cytometry. T cells cultured in vitro were mixed with untransfected DC, HBV-C-rAAV/DC, HBV-E-rAAV/DC and HBV-X-rAAV/DC respectively. Then CTLs were collected after mixed lymphocyte reaction. The expression of marker molecules on CTLs and the secretion of interferon-γ(IFN-γ) from CTLs were detected with flow cytometry, and the proliferation of T cells in vitro was detected by
3H-TdR. The killing rate of CTLs on target cells was taken through
51Cr release assay.
Results:In the negative control group and transfection groups(HBV-C-rAAV/DC, HBV-E-rAAV/DC, HBV-X-rAAV/DC), the percentages of DCs with HBV were 2.80%, 85.12%, 96.63% and 98.42% respectively. In transfection groups, the percentages of DCs with CD80 were 55.26%, 58.25% and 59.63% respectively, the expression rates of CD83 were 43.19%, 48.73% and 40.01% respectively, the expression rates of CD86 were 95.46%, 96.74% and 83.62% respectively, and the proportions of IL-12 were 47.60%, 52.50% and 69.20% respectively. In T cells induced by transfection groups, the ratios of CD8
+ CD69
+ T cells were 33.10%, 31.50% and 30.00% respectively, the proportions of CD4
+ CD25
+ T cells were 11.89%, 8.77% and 10.87% respectively, the proportions of IFN-γ were 44.65%, 45.16% and 45.16% respectively, and the in vitro proliferative capacity (cpm) of T cells were 19351, 19070 and 2642 respectively. The killing rates of CTLs induced by transfection groups on HBV antigen positive primary hepatoma cancer cells (HCC) were 61.18%, 56.93% and 65.05% respectively, on HBV antigen negative cervical cancer cells were 4.62%, 3.69% and 4.34% respectively, on primary HCC+ anti-HBV antibody were 34.90%, 27.39% and 30.66% respectively, and on primary HCC+ anti-major histocompatibility complex (MHC)-I antibody were 17.83%, 21.47% and 23.71% respectively. In transfection groups, CTLs induced by DC could effectively kill HBV positive primary HCC. With HBV antigen or MHC-I antigen decreasing, the killing ability of CTLs reduced significantly.
Conclusions:Monocytes and lymphocytes isolated from healthy human peripheral blood can be induced by specific cytokines, transfected with rAAV carrying different HBV gene and co-cultured in vitro, in order to obtain the CTLs with ability of killing HBV significantly and specifically. These CTLs with strong proliferation capacity can kill target cells continuously in vitro. The killing effect of CTLs depends on the expression of HBV antigen and MHC-I antigen.